Company Filing History:
Years Active: 2022
Title: Celebrating the Innovations of Eva Johansson
Introduction
Eva Johansson, an accomplished inventor based in Vaerloese, Denmark, has made significant contributions to the field of biotechnology. With a patented invention to her name, Johansson is at the forefront of developing innovative solutions for treating coagulopathy, notably hemophilia A.
Latest Patents
Johansson's sole patent is focused on multispecific procoagulant antibodies. This groundbreaking invention pertains to antibodies capable of binding to coagulation Factor IX (FIX) and its activated form Factor IXa (FIXa), as well as Factor X (FX) and its activated form Factor Xa (FXa). The innovation aims to promote FX activation by FIXa, offering potential methods and compositions for treating patients suffering from bleeding disorders. This patent includes kits, manufacturing processes, and methodologies for usage, marking a significant advance in the treatment landscape for individuals afflicted with such conditions.
Career Highlights
Eva Johansson currently works at Novo Nordisk A/S, a leading global healthcare company that specializes in diabetes care and hormonally-driven therapies. Her role within the company allows her to contribute to pivotal research and development initiatives in biopharmaceuticals. Johansson's focus on coagulopathy treatments not only showcases her expertise but also her commitment to improving patient outcomes.
Collaborations
In her professional journey, Johansson has collaborated with esteemed colleagues such as Karina Thorn and Bjarne Gram Hansen. Their combined efforts within Novo Nordisk A/S demonstrate a synergistic approach to tackling complex scientific challenges and developing innovative therapeutic solutions.
Conclusion
Eva Johansson exemplifies the spirit of innovation in biotechnology through her patent on procoagulant antibodies. Her contributions are essential for advancing treatments for coagulopathies like hemophilia A. As she continues her work at Novo Nordisk A/S alongside her talented colleagues, the future looks bright for Johansson and the impact her innovations will have on healthcare.